Goodwill and Other Intangible Assets (Tables)

12 Months Ended

Jun. 30, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of change in carrying amount of goodwill

	BioPharma		Consumer Health		Consolidated
	(In thousands)
Balance as of June 30, 2020	$	19,453	$	8,637	$	28,090
Goodwill acquired		37,712		—		37,712
Balance as of June 30, 2021		57,165		8,637		65,802
Goodwill impairment		(57,165)		(8,637)		(65,802)
Balance as of June 30, 2022	$	—	$	—	$	—

Schedule of finite lived intangible assets

	June 30, 2022
									Weighted-
	Gross						Net		Average
	Carrying		Accumulated				Carrying		Remaining
	Amount		Amortization		Impairment		Amount		Life (in years)
	(In thousands)
Definite-lived intangibles:
Acquired product technology right		45,400		(7,667)		(3,224)		34,509	12.33
Acquired technology right		30,200		(2,278)		—		27,922	15.75
Acquired product distribution rights		11,354		(3,581)		(2,172)		5,601	7.60
Other intangible assets		4,666		(3,004)		(1,662)		—	—
		91,620		(16,530)		(7,058)		68,032	13.35
Indefinite-lived intangibles:
Acquired in-process R&D		2,600		—		—		2,600	Indefinite-lived
		2,600		—		—		2,600
Total	$	94,220	$	(16,530)	$	(7,058)	$	70,632	13.35

	June 30, 2021
							Weighted-
	Gross						Average
	Carrying		Accumulated			Net Carrying	Remaining
	Amount		Amortization		Amount		Life (in years)
	(In thousands)
Definite-lived intangibles:
Acquired product technology right		45,400		(4,160)		41,240	12.88
Acquired technology right		30,200		(501)		29,699	16.75
Acquired product distribution rights		11,354		(2,073)		9,281	8.57
Other intangible assets		4,666		(2,022)		2,644	3.05
		91,620		(8,756)		82,864	13.47
Indefinite-lived intangibles:
Acquired in-process R&D		2,600		—		2,600	Indefinite-lived
		2,600		—		2,600
Total	$	94,220	$	(8,756)	$	85,464	13.47

Schedule of Indefinite lived intangible assets

	June 30, 2022
									Weighted-
	Gross						Net		Average
	Carrying		Accumulated				Carrying		Remaining
	Amount		Amortization		Impairment		Amount		Life (in years)
	(In thousands)
Definite-lived intangibles:
Acquired product technology right		45,400		(7,667)		(3,224)		34,509	12.33
Acquired technology right		30,200		(2,278)		—		27,922	15.75
Acquired product distribution rights		11,354		(3,581)		(2,172)		5,601	7.60
Other intangible assets		4,666		(3,004)		(1,662)		—	—
		91,620		(16,530)		(7,058)		68,032	13.35
Indefinite-lived intangibles:
Acquired in-process R&D		2,600		—		—		2,600	Indefinite-lived
		2,600		—		—		2,600
Total	$	94,220	$	(16,530)	$	(7,058)	$	70,632	13.35

	June 30, 2021
							Weighted-
	Gross						Average
	Carrying		Accumulated			Net Carrying	Remaining
	Amount		Amortization		Amount		Life (in years)
	(In thousands)
Definite-lived intangibles:
Acquired product technology right		45,400		(4,160)		41,240	12.88
Acquired technology right		30,200		(501)		29,699	16.75
Acquired product distribution rights		11,354		(2,073)		9,281	8.57
Other intangible assets		4,666		(2,022)		2,644	3.05
		91,620		(8,756)		82,864	13.47
Indefinite-lived intangibles:
Acquired in-process R&D		2,600		—		2,600	Indefinite-lived
		2,600		—		2,600
Total	$	94,220	$	(8,756)	$	85,464	13.47

Schedule of future amortization expense

	June 30,
	(In thousands)
2023	$	6,086
2024		6,074
2025		5,934
2026		5,683
2027		5,653
Thereafter		38,602
Total future amortization expense	$	68,032